FNY Investment Advisers’s AYTU BioPharma AYTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$0 Buy
110
+20
+22% +$47 ﹤0.01% 866
2026
Q1
$0 Sell
90
-31,510
-100% -$80.6K ﹤0.01% 774
2025
Q4
$82K Buy
31,600
+31,470
+24,208% +$70.6K 0.02% 369
2025
Q3
$0 Sell
130
-35,791
-100% -$82.7K ﹤0.01% 1236
2025
Q2
$78K Buy
+35,921
New +$55.8K 0.03% 329

Other funds holding AYTU

FNY Investment Advisers's AYTU Position: Q2 2026 in Review

FNY Investment Advisers increased its AYTU BioPharma (AYTU) stake by 22% in Q2 2026, buying an estimated $47 and bringing the position to 110 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #866.

FNY Investment Advisers first reported a position in AYTU in Q2 2025 and has held it in 5 quarters since. The position peaked at $82K in Q4 2025. 5 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

  • FNY Investment Advisers held 110 shares of AYTU BioPharma worth $0 as of Q2 2026.
  • FNY Investment Advisers bought 20 AYTU BioPharma shares in Q2 2026, an estimated $47.
  • AYTU BioPharma made up ﹤0.01% of FNY Investment Advisers's portfolio in Q2 2026, its #866 holding.
  • FNY Investment Advisers first reported a position in AYTU BioPharma in Q2 2025 and has held it in 5 quarters since.
  • FNY Investment Advisers's AYTU BioPharma position peaked at $82K in Q4 2025.
  • 5 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.